Truvestments Capital’s Akari Therapeutics AKTX Stock Holding History

Truvestments Capital’s Portfolio AKTX Stock Details AKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10	Hold	1	–	–	﹤0.01%	1143
2026 Q1	$5	Hold	1	–	–	﹤0.01%	1173
2025 Q4	$14	Hold	1	–	–	﹤0.01%	1025
2025 Q3	$51	Hold	1	–	–	﹤0.01%	1006
2025 Q2	$59	Hold	1	–	–	﹤0.01%	936
2025 Q1	$62	Hold	1	–	–	﹤0.01%	1007
2024 Q4	$61	Hold	1	–	–	﹤0.01%	996
2024 Q3	$148	Buy	+1	New	+$139	﹤0.01%	906
2024 Q2	–	Sell	-1	Closed	-$93	–	237
2024 Q1	$93	Hold	1	–	–	﹤0.01%	713
2023 Q4	$156	Hold	1	–	–	﹤0.01%	774
2023 Q3	$198	Hold	1	–	–	﹤0.01%	664
2023 Q2	$171	Hold	1	–	–	﹤0.01%	677
2023 Q1	$183	Hold	1	–	–	﹤0.01%	654
2022 Q4	$472	Sell	1 -1	-50%	-$414	﹤0.01%	870
2022 Q3	$1K	Hold	2	–	–	﹤0.01%	579
2022 Q2	$2K	Buy	+2	New	+$1.77K	﹤0.01%	548
2022 Q1	–	Sell	-2	Closed	-$2K	–	193
2021 Q4	$2K	Hold	2	–	–	﹤0.01%	543
2021 Q3	$3K	Hold	2	–	–	﹤0.01%	497
2021 Q2	$3K	Hold	2	–	–	﹤0.01%	503
2021 Q1	$4K	Sell	2 -1	-33%	-$2.27K	﹤0.01%	533
2020 Q4	$3K	Buy	+3	New	+$4.16K	﹤0.01%	521
2020 Q3	–	Sell	-3	Closed	-$4K	–	320
2020 Q2	$4K	Buy	+3	New	+$4.57K	﹤0.01%	467
2019 Q4	–	Sell	-5	Closed	-$6K	–	153
2019 Q3	$6K	Hold	5	–	–	﹤0.01%	546
2019 Q2	$8K	Hold	5	–	–	0.01%	548
2019 Q1	$14K	Buy	+5	New	+$9.54K	0.01%	458
2018 Q3	$11K	Buy	+5	New	+$8.07K	0.01%	612

Other funds holding AKTX

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Truvestments Capital's AKTX Position: Q2 2026 in Review

Truvestments Capital held its Akari Therapeutics (AKTX) position steady in Q2 2026 at 1 share worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Truvestments Capital first reported a position in AKTX in Q3 2018 and has held it in 26 quarters since. The position peaked at $14K in Q1 2019. 9 funds tracked by Wall St. Rank hold AKTX as of Q2 2026.

Truvestments Capital held 1 share of Akari Therapeutics worth $10 as of Q2 2026.
Truvestments Capital left its Akari Therapeutics share count unchanged in Q2 2026.
Akari Therapeutics made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #1143 holding.
Truvestments Capital first reported a position in Akari Therapeutics in Q3 2018 and has held it in 26 quarters since.
Truvestments Capital's Akari Therapeutics position peaked at $14K in Q1 2019.
9 funds tracked by Wall St. Rank held Akari Therapeutics as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.